Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
4.230
-0.040 (-0.94%)
Jun 12, 2025, 2:45 PM CST
SHE:002424 Revenue
Guizhou Bailing Group Pharmaceutical had revenue of 760.59M CNY in the quarter ending March 31, 2025, a decrease of -42.93%. This brings the company's revenue in the last twelve months to 3.25B, down -27.77% year-over-year. In the year 2024, Guizhou Bailing Group Pharmaceutical had annual revenue of 3.83B, down -10.26%.
Revenue (ttm)
3.25B
Revenue Growth
-27.77%
P/S Ratio
1.79
Revenue / Employee
493.96K
Employees
6,582
Market Cap
5.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.83B | -437.59M | -10.26% |
Dec 31, 2023 | 4.26B | 722.84M | 20.42% |
Jan 1, 2023 | 3.54B | 429.01M | 13.79% |
Jan 1, 2022 | 3.11B | 23.24M | 0.75% |
Dec 31, 2020 | 3.09B | 237.30M | 8.32% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |